Participating in the launch of «Takeda» production line for the Ixazomib in Yaroslavl
On August 1, 2018, Vladislav Shestakov, Director of the FSI “SID and GP”, took part in the opening ceremony at the for the production line for the Ixazomib, an innovative medicine for patients with multiple myeloma. The ceremony was held in Yaroslavl plant of «Takeda Pharmaceuticals». The total investment in the Russian production of the medicine amounted to 477 million rubles.
The solemn opening ceremony also saw the attendance: Governor of Yaroslavl region – Dmitry Mironov; Head of the Department of Pharmaceutical and Medical Industry Development of Minpromtorg Russia – Aleksey Alekhin; Director of the Europe Department of the Ministry of Foreign Affairs of Japan – Yasushi Masaki; Representative of the Yaroslavl region in the Federation Council – Igor Kagramanyan; CEO of the “Takeda Russia”, the Head of the CIS – Andrey Potapov; Director of the “Takeda Yaroslavl” Macey Fabiancic.
Other materials
- FSI “SID & GP” and CDSCO, India signed a cooperation agreement.
- The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party
- The program of the IX All-Russian GMP Conference with international participation has been published
- Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products
- Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”
